IBOV 171,324.31 ▼ 0.43% IPC MEX 71,674.32 ▼ 0.46% MERVAL 2,848,945 — — USD/BRL5.65▲ 1.12% USD/MXN18.59▼ 0.04% USD/CLP994.00▲ 1.14% USD/COP3,303▼ 0.13% USD/PEN3.41▼ 0.04% USD/ARS1,545▲ 0.03% USD/UYU40.52▲ 3.32% USD/PYG6,185▲ 3.33% USD/BOB11.60▲ 0.86% USD/DOP60.59▲ 0.23% USD/CRC445.25▲ 1.62% USD/GTQ7.65▲ 3.31% USD/HNL26.90▲ 3.30% USD/NIO36.62▲ 2.73% USD/VES902.19▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.09▲ 2.15% USD/TTD6.71▲ 2.19% EUR/BRL6.25▲ 0.28% BRENT 95.77 ▲ 3.24% WTI 88.70 ▲ 2.51% IRON ORE 161.91 — — COPPER 6.19 ▼ 1.30% GOLD 3,882 ▼ 2.97% SILVER 49.96 ▼ 3.71% SOY 1,220 ▼ 0.77% CORN 442.25 ▼ 1.28% WHEAT 582.50 ▼ 2.84% COFFEE 275.10 ▲ 2.27% SUGAR 18.22 ▼ 1.41% ORANGE JUICE 140.60 ▼ 3.53% COTTON 78.56 ▲ 0.05% COCOA 5,187 ▲ 5.71% BEEF 223.05 ▲ 1.86% CATTLE 331.80 ▼ 0.25% LITHIUM 59.43 ▼ 2.69% PETR4 44.70 ▲ 2.64% VALE3 63.95 ▼ 0.75% ITUB4 41.68 ▼ 0.10% BBDC4 14.32 ▼ 0.07% ABEV3 15.75 ▼ 0.63% BBAS3 15.48 ▼ 8.35% B3SA3 14.76 ▼ 0.27% WEGE3 51.65 ▲ 0.08% PRIO3 63.30 ▲ 2.98% SUZB3 56.04 ▲ 4.16% RENT3 29.58 ▼ 2.18% AZZA3 16.90 ▲ 9.95% CSAN3 2.85 ▼ 5.94% RAIZ4 0.30 ▼ 98.60% PCAR3 2.39 ▼ 5.91% GMAT3 3.84 ▼ 5.88% PSSA3 45.94 ▼ 0.09% CVCB3 0.84 ▼ 2.33% POSI3 3.37 ▲ 1.51% SLCE3 18.36 ▲ 7.68% NATU3 5.33 ▼ 5.16% BRKM5 3.07 ▲ 5.14% RANI3 8.18 ▼ 2.50% CSNA3 4.23 ▼ 6.42% IBOV 171,324.31 ▼ 0.43% IPC MEX 71,674.32 ▼ 0.46% MERVAL 2,848,945 — — USD/BRL 5.65 ▲ 1.12% USD/MXN 18.60 ▼ 0.02% USD/CLP 994.00 ▲ 1.14% USD/COP 3,308 ▲ 0.02% USD/PEN 3.41 ▼ 0.08% USD/ARS 1,545 ▲ 0.03% USD/UYU 40.52 ▲ 3.32% USD/PYG 6,185 ▲ 3.33% USD/BOB 11.60 ▲ 0.86% USD/DOP 60.47 ▲ 0.03% USD/CRC 445.25 ▲ 1.62% USD/GTQ 7.65 ▲ 3.31% USD/HNL 26.90 ▲ 3.30% USD/NIO 36.62 ▲ 2.73% USD/VES 902.19 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.09 ▲ 2.15% USD/TTD 6.71 ▲ 2.19% EUR/BRL 6.25 ▲ 0.28% BRENT 95.77 ▲ 3.24% WTI 88.70 ▲ 2.51% IRON ORE 161.91 — — COPPER 6.19 ▼ 1.30% GOLD 3,882 ▼ 2.97% SILVER 49.96 ▼ 3.71% SOY 1,220 ▼ 0.77% CORN 442.25 ▼ 1.28% WHEAT 582.50 ▼ 2.84% COFFEE 275.10 ▲ 2.27% SUGAR 18.22 ▼ 1.41% ORANGE JUICE 140.60 ▼ 3.53% COTTON 78.56 ▲ 0.05% COCOA 5,187 ▲ 5.71% BEEF 223.05 ▲ 1.86% CATTLE 331.80 ▼ 0.25% LITHIUM 59.43 ▼ 2.69% PETR4 44.70 ▲ 2.64% VALE3 63.95 ▼ 0.75% ITUB4 41.68 ▼ 0.10% BBDC4 14.32 ▼ 0.07% ABEV3 15.75 ▼ 0.63% BBAS3 15.48 ▼ 8.35% B3SA3 14.76 ▼ 0.27% WEGE3 51.65 ▲ 0.08% PRIO3 63.30 ▲ 2.98% SUZB3 56.04 ▲ 4.16% RENT3 29.58 ▼ 2.18% AZZA3 16.90 ▲ 9.95% CSAN3 2.85 ▼ 5.94% RAIZ4 0.30 ▼ 98.60% PCAR3 2.39 ▼ 5.91% GMAT3 3.84 ▼ 5.88% PSSA3 45.94 ▼ 0.09% CVCB3 0.84 ▼ 2.33% POSI3 3.37 ▲ 1.51% SLCE3 18.36 ▲ 7.68% NATU3 5.33 ▼ 5.16% BRKM5 3.07 ▲ 5.14% RANI3 8.18 ▼ 2.50% CSNA3 4.23 ▼ 6.42%
since 2009
Thursday, November 12, 2026

Latest News Latin America

Is Cuban Drug Key to Treating Coronavirus?

By · · 3 min read

RIO DE JANEIRO, BRAZIL – The Cuban drug “Recombinant Interferon alfa 2b (IFNrec)” is one of 30 drugs selected to fight the coronavirus Covid-19 in China. According to media reports, it has already cured more than 1,500 patients. Since January 25th, it has been produced in the Chinese-Cuban plant Chanheber in the province of Jilin, according to the Cuban embassy in China.

According to specialists, it has so far been used to treat viral infections such as HIV/AIDS, recurrent respiratory papillomatosis, a respiratory tumor, and hepatitis B and C.

Developed in 1986 by Cuban researchers at the Center for Genetic Engineering and Biotechnology (CIGB), it has helped thousands of patients since its introduction more than 30 years ago. It inhibits the replication process of the virus within the cells, an action that has also had success in the treatment of various types of cancer.

Free daily brief — no card needed
Get every Latest News story in one morning email
We build you a personalized brief around the topics you follow — free for 7 days. Love it? Your first month after that is US$1.
The Cuban drug "Recombinant Interferon alfa 2b (IFNrec)" is one of 30 drugs selected to fight the coronavirus in China. According to media reports, it has already cured more than 1,500 patients.
The Cuban drug “Recombinant Interferon alfa 2b (IFNrec)” is one of 30 drugs selected to fight the coronavirus in China. According to media reports, it has already cured more than 1,500 patients.
RT
Ask Rio Times
17 years of Latin America reporting, on demand.
Open the full Ask Rio Times →

Through a technology transfer from CIGB to China in 2003, the Changheber Sino-Cuban joint venture was established in the city of Changchung and a decade later a modern production center was inaugurated.

This is where biotechnological products are developed and produced, including the drug IFNrec, which can be used against the coronavirus. In 2012, IFNrec received the National Technology Innovation Prize in Cuba, awarded by the Cuban Ministry of Science, Technology and Environment, and the National Health Prize in 2013.

The LatAm Brief

One email, every weekday morning. What moved in Latin American markets, politics and expat life.

Yesterday’s subject line: “Colombia's president announces a new cartel airstrike”

The decision of the Chinese health authorities to use the drug is based on the way the coronavirus acts, which reduces the natural production of interferon in the body. The Cuban drug can offset this deficit and strengthen the immune system of patients suffering from the infectious respiratory disease.

At a meeting between Cuban President Miguel Díaz-Canel and Chinese Ambassador Chen Xi in Havana last Friday, Díaz-Canel underlined Cuba’s willingness to assist China in all necessary steps to fight the virus. He further stressed that China has “the necessary experience and capable leadership to overcome adversity” and praised their great sense of responsibility in dealing with the virus.

Cuba’s Foreign Minister Bruno Rodríguez twittered last Monday that it is solidarity that distinguishes Cuba from other countries. He said that 56 years of medical cooperation, with a presence in 164 countries and the involvement of more than 4,000 doctors, is evidence of this principle, which Cuba will continue to uphold: “We practice it, as Fidel said, with facts, not with fine words”. On March 23rd, 1963, a medical team of 56 doctors was deployed in Algeria for the first time.

In early February, the US antiviral drug Remedevisir was considered a potential solution to the coronavirus and tested on more than 700 patients. Originally developed for the treatment of Ebola, it had shown promising effects with other coronaviruses such as SARS or MERS and eased the disease symptoms of patients treated within a short time. Currently, the drug is only approved for clinical trials.

Relevant studies are currently being conducted at the Chinese Academy and in hospitals in Wuhan. However, it is necessary to wait for the results of these studies. The Chinese government has already applied for a national patent on the drug, which was developed by the US company Gilead Sciences and is currently the subject of disputes regarding the ownership and use of intellectual property.

According to the latest figures, there are currently over 77,000 confirmed Covid-19 infections in 26 countries, of which more than 74,000 are in China. Over 2,200 of these have been fatal.

This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →

Brazil runoff date: Sunday, October 25, poll closing times and when results start · Brazil runoff polls: Flávio 51%, Lula 49% · Kalshi and Polymarket odds

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.